Securities code: 002622 securities abbreviation: Rongyu Group Co.Ltd(002622) Announcement No.: 2022-002
2021 annual performance forecast
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records
Contains, misleading statements or material omissions.
1、 Expected performance of the current period
(I) performance forecast period: January 1, 2021 – December 31, 2021
(II) performance forecast: □√
Same period last year
Current reporting period of the project
Before and after reorganization
Losses attributable to listed companies: 92 million yuan – 55 million yuan
Loss: 297.1243 million yuan loss: 306.96 million yuan net profit of shareholders increased by 69.04% – 81.49% over the same period last year
Deducting non recurring losses: 95 million yuan – 58 million yuan
Loss: 328122600 yuan, loss: 342820700 yuan, net profit after profit increased by 71.05% – 82.32% over the same period of last year
Loss of basic earnings per share: 0.1095 yuan / share – 0.0655 yuan / share loss: 0.3537 yuan / share loss: 0.3654 yuan / share
Note: during the reporting period, the company completed major asset restructuring and purchased Guangzhou Delun Medical Investment Co., Ltd. (hereinafter referred to as “Delun”) by paying cash
51% equity of “Delun medical”). According to the regulations of Shenzhen Stock Exchange, companies that have completed major asset restructuring in the current year shall also list the pre restructuring
Data of the same period of last year after. In the above table, the data in the same period of last year (before reorganization) is the audited data of the company in 2020, and the data in the same period of last year (after reorganization)
The data is the reference data assuming that the major asset purchase has been completed in the same period of last year.
2、 Communication with accounting firms
This performance forecast has not been pre audited by certified public accountants. Matters related to the company’s employment performance forecast and accounting matters
The accounting firm has conducted pre communication, and there is no major difference between the company and the accounting firm in terms of performance forecast.
3、 Explanation of performance change reasons
The main reasons for the change of the company’s performance during the reporting period are as follows:
1. During the reporting period, despite the adverse factors such as covid-19 epidemic, China’s overall economic trend remained stable
Good, the company’s industrial sector revenue increased year-on-year. At the same time, the company’s acquisition of the controlling interest of Delong medical completed the asset transfer and relevant industrial and commercial change registration procedures on November 18, 2021. Delong medical became the holding subsidiary of the company, and Delong medical was included in the scope of the company’s consolidated statements in December 2021.
2. During the reporting period, with the company’s successful layout in the field of oral medical services, the overall quality of the company’s assets improved, and the provision for asset impairment decreased significantly year-on-year.
3. Affected by the market economic environment and other factors, Fushun Bank Co., Ltd., an associate of the company, made large impairment reserves, resulting in a large decline in the company’s investment income.
4、 Risk tips
This performance forecast is the preliminary calculation result of the company’s financial department. Without audit, the specific financial data will be disclosed in detail in the company’s 2021 annual report. Please make careful decisions and pay attention to investment risks.
It is hereby announced.
Rongyu Group Co.Ltd(002622) board of directors January 28, 2002
